| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |